vs
Side-by-side financial comparison of Esperion Therapeutics, Inc. (ESPR) and Paymentus Holdings, Inc. (PAY). Click either name above to swap in a different company.
Paymentus Holdings, Inc. is the larger business by last-quarter revenue ($330.5M vs $168.4M, roughly 2.0× Esperion Therapeutics, Inc.). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs 28.1%). Over the past eight quarters, Paymentus Holdings, Inc.'s revenue compounded faster (33.7% CAGR vs 10.6%).
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
Paymentus Holdings, Inc. is a leading cloud-based bill payment and customer engagement technology provider. It offers integrated digital payment solutions, billing automation tools, and self-service portals for enterprises across utilities, financial services, government, healthcare, and telecommunications segments, primarily operating in the North American market.
ESPR vs PAY — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $168.4M | $330.5M |
| Net Profit | — | $20.7M |
| Gross Margin | — | 25.4% |
| Operating Margin | 50.6% | 7.3% |
| Net Margin | — | 6.3% |
| Revenue YoY | 143.7% | 28.1% |
| Net Profit YoY | — | 57.2% |
| EPS (diluted) | $0.32 | $0.16 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $168.4M | $330.5M | ||
| Q3 25 | $87.3M | $310.7M | ||
| Q2 25 | $82.4M | $280.1M | ||
| Q1 25 | $65.0M | $275.2M | ||
| Q4 24 | $69.1M | $257.9M | ||
| Q3 24 | $51.6M | $231.6M | ||
| Q2 24 | $73.8M | $197.4M | ||
| Q1 24 | $137.7M | $184.9M |
| Q4 25 | — | $20.7M | ||
| Q3 25 | $-31.3M | $17.7M | ||
| Q2 25 | $-12.7M | $14.7M | ||
| Q1 25 | $-40.5M | $13.8M | ||
| Q4 24 | — | $13.1M | ||
| Q3 24 | $-29.5M | $14.4M | ||
| Q2 24 | $-61.9M | $9.4M | ||
| Q1 24 | $61.0M | $7.2M |
| Q4 25 | — | 25.4% | ||
| Q3 25 | — | 24.1% | ||
| Q2 25 | — | 25.5% | ||
| Q1 25 | — | 24.0% | ||
| Q4 24 | — | 25.6% | ||
| Q3 24 | — | 26.2% | ||
| Q2 24 | — | 29.8% | ||
| Q1 24 | — | 28.5% |
| Q4 25 | 50.6% | 7.3% | ||
| Q3 25 | -11.4% | 6.4% | ||
| Q2 25 | 8.6% | 5.7% | ||
| Q1 25 | -34.0% | 5.7% | ||
| Q4 24 | -6.4% | 5.5% | ||
| Q3 24 | -31.0% | 5.2% | ||
| Q2 24 | 3.5% | 5.2% | ||
| Q1 24 | 52.5% | 4.5% |
| Q4 25 | — | 6.3% | ||
| Q3 25 | -35.9% | 5.7% | ||
| Q2 25 | -15.4% | 5.3% | ||
| Q1 25 | -62.2% | 5.0% | ||
| Q4 24 | — | 5.1% | ||
| Q3 24 | -57.2% | 6.2% | ||
| Q2 24 | -83.9% | 4.7% | ||
| Q1 24 | 44.3% | 3.9% |
| Q4 25 | $0.32 | $0.16 | ||
| Q3 25 | $-0.16 | $0.14 | ||
| Q2 25 | $-0.06 | $0.11 | ||
| Q1 25 | $-0.21 | $0.11 | ||
| Q4 24 | $-0.14 | $0.11 | ||
| Q3 24 | $-0.15 | $0.11 | ||
| Q2 24 | $-0.33 | $0.07 | ||
| Q1 24 | $0.34 | $0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.9M | $320.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-302.0M | $560.4M |
| Total Assets | $465.9M | $667.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.9M | $320.9M | ||
| Q3 25 | $92.4M | $287.9M | ||
| Q2 25 | $86.1M | $266.4M | ||
| Q1 25 | $114.6M | $245.8M | ||
| Q4 24 | $144.8M | $205.9M | ||
| Q3 24 | $144.7M | $187.5M | ||
| Q2 24 | $189.3M | $188.8M | ||
| Q1 24 | $226.6M | $180.1M |
| Q4 25 | $-302.0M | $560.4M | ||
| Q3 25 | $-451.4M | $537.4M | ||
| Q2 25 | $-433.5M | $516.7M | ||
| Q1 25 | $-426.2M | $500.4M | ||
| Q4 24 | $-388.7M | $485.6M | ||
| Q3 24 | $-370.2M | $468.8M | ||
| Q2 24 | $-344.2M | $451.6M | ||
| Q1 24 | $-294.3M | $439.4M |
| Q4 25 | $465.9M | $667.9M | ||
| Q3 25 | $364.0M | $644.4M | ||
| Q2 25 | $347.1M | $609.5M | ||
| Q1 25 | $324.0M | $590.9M | ||
| Q4 24 | $343.8M | $576.2M | ||
| Q3 24 | $314.1M | $552.9M | ||
| Q2 24 | $352.3M | $527.7M | ||
| Q1 24 | $373.1M | $514.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $45.2M | $45.1M |
| Free Cash FlowOCF − Capex | — | $45.0M |
| FCF MarginFCF / Revenue | — | 13.6% |
| Capex IntensityCapex / Revenue | 0.0% | 0.0% |
| Cash ConversionOCF / Net Profit | — | 2.18× |
| TTM Free Cash FlowTrailing 4 quarters | — | $161.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $45.2M | $45.1M | ||
| Q3 25 | $-4.3M | $35.1M | ||
| Q2 25 | $-31.4M | $31.5M | ||
| Q1 25 | $-22.6M | $50.4M | ||
| Q4 24 | $-35.0M | $27.9M | ||
| Q3 24 | $-35.3M | $6.7M | ||
| Q2 24 | $-7.2M | $18.0M | ||
| Q1 24 | $53.8M | $11.0M |
| Q4 25 | — | $45.0M | ||
| Q3 25 | — | $35.0M | ||
| Q2 25 | — | $31.4M | ||
| Q1 25 | — | $50.4M | ||
| Q4 24 | — | $27.8M | ||
| Q3 24 | $-35.5M | $6.7M | ||
| Q2 24 | $-7.3M | $17.8M | ||
| Q1 24 | $53.8M | $10.8M |
| Q4 25 | — | 13.6% | ||
| Q3 25 | — | 11.3% | ||
| Q2 25 | — | 11.2% | ||
| Q1 25 | — | 18.3% | ||
| Q4 24 | — | 10.8% | ||
| Q3 24 | -68.7% | 2.9% | ||
| Q2 24 | -9.9% | 9.0% | ||
| Q1 24 | 39.0% | 5.9% |
| Q4 25 | 0.0% | 0.0% | ||
| Q3 25 | 0.0% | 0.0% | ||
| Q2 25 | 0.0% | 0.0% | ||
| Q1 25 | 0.0% | 0.0% | ||
| Q4 24 | 0.0% | 0.0% | ||
| Q3 24 | 0.3% | 0.0% | ||
| Q2 24 | 0.1% | 0.1% | ||
| Q1 24 | 0.1% | 0.1% |
| Q4 25 | — | 2.18× | ||
| Q3 25 | — | 1.98× | ||
| Q2 25 | — | 2.14× | ||
| Q1 25 | — | 3.65× | ||
| Q4 24 | — | 2.12× | ||
| Q3 24 | — | 0.47× | ||
| Q2 24 | — | 1.93× | ||
| Q1 24 | 0.88× | 1.52× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
PAY
| Payment Transaction Processing Revenue | $326.9M | 99% |
| Other | $3.5M | 1% |